Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...
47m
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth ...
Berenberg analyst Luisa Hector lowered the firm’s price target on Merck (MRK) to $115 from $125 and keeps a Buy rating on the shares. Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback